Evidence map›Paper›PMID 23428890›Full record

ArticlePlant signaling & behavior2013

NAD⁺ accumulation as a metabolic off switch for orthodox pollen.

Shin-Nosuke Hashida, Maki Kawai-Yamada, Hirofumi Uchimiya

Open access · hybridAbstract read
In one paragraph

Article in Plant signaling & behavior, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 3 countries.

Shin-Nosuke HashidaEnvironmental Science Research Laboratory; Central Research Institute of Electric Power Industry (CRIEPI); Abiko-shi Chiba, Japan.
Maki Kawai-Yamada
Hirofumi Uchimiya
Saitama University · JPCentral Research Institute of Electric Power Industry · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Terrestrial plant pollen is classified into two categories based on its metabolic status: pollen with low-metabolism are termed "orthodox" and pollen with high-metabolism are termed "recalcitrant." Nicotinamide adenine dinucleotide (NAD) is crucial for a number of metabolisms in all extant organisms. It has recently been shown that NAD homeostasis plays an important role in a broad range of developmental processes and responses to environment. Recently, a reverse genetic approach shed light on the significance of NAD biosynthesis on pollen fate. In orthodox Arabidopsis pollen, NAD(+) that was accumulated in excess at dispersal dramatically decreased on rehydration. The lack of a key gene that is involved in NAD biosynthesis compromised the excess accumulation. Moreover, absence of the excess accumulation phenocopied the so-called recalcitrant pollen, as demonstrated by the germination inside anthers and the loss of desiccation tolerance. Upon rehydration, NAD(+)-consuming inhibitors impaired tube germination. Taken together, our results suggest that accumulation of NAD(+) functions as a physiochemical molecular switch for suspended metabolism and that the decrease of NAD(+) plays a very important role during transitions in metabolic states. Shifting of the redox state to an oxidizing environment may efficiently control the comprehensive metabolic network underlying the onset of pollen germination.

Indexed as

ArabidopsisArabidopsis ProteinsHomeostasisNADNicotinamide-Nucleotide AdenylyltransferaseOxidation-ReductionPollenArabidopsis ProteinsNADNicotinamide-Nucleotide AdenylyltransferasegerminationNAD biosynthesisNAD homeostasisnicotinamide adenine dinucleotide (NAD)pollenredox

Identifiers

PMID23428890
PMCPMC3906144
OpenAlexW2094361344

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.